Literature DB >> 27460346

Japanese multiple epidermal growth factor 10 (MEGF10) myopathy with novel mutations: A phenotype-genotype correlation.

Kazuko Takayama1, Satomi Mitsuhashi2, Je-Young Shin1, Rieko Tanaka3, Tatsuya Fujii4, Rie Tsuburaya5, Souichi Mukaida5, Satoru Noguchi1, Ikuya Nonaka1, Ichizo Nishino6.   

Abstract

Mutations in the multiple epidermal growth factor-like domains 10 (MEGF10: NM_032446.2) gene are known to cause early-onset myopathy characterized by areflexia, respiratory distress, and dysphagia (EMARDD: OMIM 614399), and a milder phenotype of minicore myopathy. To date, there have been reports of six families with EMARDD and one with a milder disorder. Cysteine mutations in the extracellular EGF-like domain may be responsible for the milder phenotype, but the relationship is not conclusive because of the few reports of this disorder. We here present two Japanese patients with MEGF10 mutations: one with EMARDD phenotype who had a novel homozygous frameshift mutation, c.131_132del, and the other with the milder phenotype who harbored a compound heterozygous mutation, c.2981-2A > G, and a novel missense mutation, p.Cys810Tyr. This is the first report on East Asian patients with MEGF10 myopathy showing two phenotypes, indicating the genotype-phenotype correlation in MEGF10 myopathy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MEGF10; Myopathy; Satellite cell

Mesh:

Substances:

Year:  2016        PMID: 27460346     DOI: 10.1016/j.nmd.2016.06.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

1.  Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.

Authors:  Madhurima Saha; Skylar A Rizzo; Manashwi Ramanathan; Rylie M Hightower; Katherine E Santostefano; Naohiro Terada; Richard S Finkel; Jonathan S Berg; Nizar Chahin; Christina A Pacak; Richard E Wagner; Matthew S Alexander; Isabelle Draper; Peter B Kang
Journal:  Hum Mol Genet       Date:  2019-07-15       Impact factor: 6.150

Review 2.  Cored in the act: the use of models to understand core myopathies.

Authors:  Aurora Fusto; Louise A Moyle; Penney M Gilbert; Elena Pegoraro
Journal:  Dis Model Mech       Date:  2019-12-19       Impact factor: 5.758

3.  Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies.

Authors:  Massimo Ganassi; Francesco Muntoni; Peter S Zammit
Journal:  Exp Cell Res       Date:  2021-11-03       Impact factor: 3.905

4.  Phenotypic Variability of MEGF10 Variants Causing Congenital Myopathy: Report of Two Unrelated Patients from a Highly Consanguineous Population.

Authors:  Mohammad AlMuhaizea; Omar Dabbagh; Hanan AlQudairy; Aljouhra AlHargan; Wafa Alotaibi; Ruba Sami; Rahaf AlOtaibi; Mariam Mahmoud Ali; Hindi AlHindi; Dilek Colak; Namik Kaya
Journal:  Genes (Basel)       Date:  2021-11-10       Impact factor: 4.096

Review 5.  The Notch signaling network in muscle stem cells during development, homeostasis, and disease.

Authors:  Stamatia Gioftsidi; Frederic Relaix; Philippos Mourikis
Journal:  Skelet Muscle       Date:  2022-04-22       Impact factor: 5.063

Review 6.  Mutations in proteins involved in E-C coupling and SOCE and congenital myopathies.

Authors:  Daniela Rossi; Maria Rosaria Catallo; Enrico Pierantozzi; Vincenzo Sorrentino
Journal:  J Gen Physiol       Date:  2022-08-18       Impact factor: 4.000

Review 7.  Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction.

Authors:  Heinz Jungbluth; Susan Treves; Francesco Zorzato; Anna Sarkozy; Julien Ochala; Caroline Sewry; Rahul Phadke; Mathias Gautel; Francesco Muntoni
Journal:  Nat Rev Neurol       Date:  2018-02-02       Impact factor: 42.937

8.  MEGF11 is related to tumour recurrence in triple negative breast cancer via chemokine upregulation.

Authors:  Jen-Hwey Chiu; Ling-Ming Tseng; Tzu-Ting Huang; Chun-Yu Liu; Jir-You Wang; Ching-Po Huang; Yi-Fang Tsai; Chih-Yi Hsu
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

9.  Megf10 deficiency impairs skeletal muscle stem cell migration and muscle regeneration.

Authors:  Chengcheng Li; Dorianmarie Vargas-Franco; Madhurima Saha; Rachel M Davis; Kelsey A Manko; Isabelle Draper; Christina A Pacak; Peter B Kang
Journal:  FEBS Open Bio       Date:  2020-11-26       Impact factor: 2.792

10.  Insights into the ligand binding specificity of SREC-II (scavenger receptor expressed by endothelial cells).

Authors:  Catherine Wicker-Planquart; Pascale Tacnet-Delorme; Laurence Preisser; Samy Dufour; Yves Delneste; Dominique Housset; Philippe Frachet; Nicole M Thielens
Journal:  FEBS Open Bio       Date:  2021-09-12       Impact factor: 2.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.